Chromodulin (LMWCr)
The oligopeptide that amplifies insulin signaling using chromium
Definition
Chromodulin —also called low-molecular-weight chromium-binding substance (LMWCr)— is an oligopeptide of roughly four amino acids (glycine, cysteine, glutamate and aspartate) able to bind up to four trivalent chromium ions. Its proposed role is to amplify insulin signaling: when the insulin receptor is activated, chromium-loaded chromodulin binds to it and boosts its tyrosine kinase activity. It is the biochemical mechanism that explains why dietary chromium influences glucose metabolism, linking a trace mineral to the insulin cascade at the molecular level.
Detailed explanation
Chromodulin was largely characterized by John B. Vincent's group across the 1990s and 2000s. At rest, the apopeptide (chromium-free) is biologically inactive. When rising glucose elevates insulin, the hormone binds its membrane receptor; the signal triggers mobilization of trivalent chromium from transferrin toward apochromodulin stored inside the cell.
Once loaded with four Cr³⁺ ions (holochromodulin), the peptide binds the intracellular domain of the already-activated insulin receptor and multiplies its tyrosine kinase activity —up to eightfold in adipocyte membrane fragments— with a dissociation constant in the picomolar range (~250 pM). This constitutes an autoamplification mechanism for insulin signaling.
When insulin falls, holochromodulin is released from the cell and cleared in the urine, terminating the signal. This transferrin→chromodulin→receptor→urine cycle is the leading mechanistic hypothesis for how dietary chromium (e.g. chromium picolinate) might modulate insulin sensitivity, though its clinical relevance in humans remains debated.
Scientific sources
- PubMed — Chromium oligopeptide activates insulin receptor tyrosine kinase activity (Davis & Vincent)
- PubMed — The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin (Vincent)
- PubMed — Quest for the molecular mechanism of chromium action and its relationship to diabetes (Vincent)
- PubMed — Isolation and characterization of low-molecular-weight chromium-binding substance (LMWCr) from chicken liver
Interested in related treatments?
Generate My Protocol